InsidersTradesSigma
Discover the detailed record of transactions filed by Perez Edith A., Directeur Médical. Officer active across 1 companies, notably Bolt Biotherapeutics, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €25k. The latest transaction was disclosed on 4 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Edith A. Perez is the Chief Medical Officer of Bolt Biotherapeutics, Inc. She is responsible for the company's medical direction, overseeing research and development initiatives and ensuring compliance with regulatory standards. Edith plays a key role in developing innovative therapeutic solutions and improving patient outcomes.